Explore more publications!
Health Daily Finland
Got News to Share?

Press Releases

Verdane Invests in Clue to Accelerate the Future of Women’s Health
January 15, 2026

Verdane Invests in Clue to Accelerate the Future of Women’s Health

Indeterminate GlobeNewswire, Inc.
Mpac Lambert Partners with GlucoModicum to Deliver Scalable Automation for Needle-Free Glucose Monitoring Sensor
January 15, 2026

Mpac Lambert Partners with GlucoModicum to Deliver Scalable Automation for Needle-Free Glucose Monitoring Sensor

Neutral EIN Presswire
What is the Open Dialogue approach in mental health?
January 12, 2026

What is the Open Dialogue approach in mental health?

Neutral Rethink Mental Illness
Owner: Rethink Mental Illness (Non-profit)

Rethink Mental Illness

Neutral
Owned By Rethink Mental Illness (Non-profit, Mark Winstanley Chief Executive)
Year Founded 1970
Website www.rethink.org
Domain Registration Year Indeterminate
Access Type open
Publication Location United Kingdom, London
Owner Country United Kingdom

We welcome your feedback!
If you have comments or corrections, let us know.

VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026

VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire, Inc.
First Quantum Minerals Announces 2025 Preliminary Production and 2026 - 2028 Guidance
January 15, 2026

First Quantum Minerals Announces 2025 Preliminary Production and 2026 - 2028 Guidance

Indeterminate GlobeNewswire, Inc.
Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)
January 8, 2026

Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)

Indeterminate GlobeNewswire, Inc.
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease
January 7, 2026

Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease

Indeterminate GlobeNewswire, Inc.
Finland Set to Raise Military Reserve Age to 65
December 23, 2025

Finland Set to Raise Military Reserve Age to 65

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

OTC Markets Group Announces the 2026 OTCQX Best 50
January 15, 2026

OTC Markets Group Announces the 2026 OTCQX Best 50

Indeterminate GlobeNewswire, Inc.
Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future
January 14, 2026

Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future

Indeterminate GlobeNewswire, Inc.
At the Yacht Club de Monaco, young sailors are ready for the Monaco Optimist Team Race
January 14, 2026

At the Yacht Club de Monaco, young sailors are ready for the Monaco Optimist Team Race

Indeterminate GlobeNewswire, Inc.
Tackling the Global "Compute Shortage": 3 E Network Technology Unveils a Next-Gen AI Data Center Solution
January 14, 2026

Tackling the Global "Compute Shortage": 3 E Network Technology Unveils a Next-Gen AI Data Center Solution

Indeterminate GlobeNewswire, Inc.
Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities
January 8, 2026

Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities

Indeterminate GlobeNewswire, Inc.
Drug Trials Snapshots: LYNKUET
December 30, 2025

Drug Trials Snapshots: LYNKUET

Gov't Institution U.S. Food and Drug Administration
Owner: American Government

U.S. Food and Drug Administration

Gov't Institution
Owned By American Government through Department of Health and Human Services
Year Founded 1906
Website www.fda.gov
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, Maryland, Silver Springs
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization
January 9, 2026

Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization

Indeterminate GlobeNewswire, Inc.
Panoramic X-Rays Market set for steady growth to US$ 48.13 billion by 2033, led by North America 39% global market share
December 19, 2025

Panoramic X-Rays Market set for steady growth to US$ 48.13 billion by 2033, led by North America 39% global market share

Neutral EIN Presswire
Peptide Therapeutics Market Size to Surpass USD 87.21 Billion by 2035 Driven by Rising Cancer, Diabetes, and Demand for Targeted Therapies
December 18, 2025

Peptide Therapeutics Market Size to Surpass USD 87.21 Billion by 2035 Driven by Rising Cancer, Diabetes, and Demand for Targeted Therapies

Indeterminate GlobeNewswire, Inc.
Curium Announces First Commercial Doses of PYLCLARI® for Patients with Prostate Cancer in Poland
December 23, 2025

Curium Announces First Commercial Doses of PYLCLARI® for Patients with Prostate Cancer in Poland

Indeterminate GlobeNewswire, Inc.
Europe, Japan, Canada raise concerns over Gaza humanitarian crisis
December 31, 2025

Europe, Japan, Canada raise concerns over Gaza humanitarian crisis

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

European Nations, Japan, Canada Voice Concerns Over Gaza
December 31, 2025

European Nations, Japan, Canada Voice Concerns Over Gaza

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions